Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02238691
Other study ID # Pelles PEEP-studie
Secondary ID
Status Completed
Phase N/A
First received August 13, 2014
Last updated April 4, 2016
Start date February 2015
Est. completion date September 2015

Study information

Verified date April 2016
Source Örebro University, Sweden
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

Continuous positive pressure during anesthetic induction is today not routinely used partly a to the risk of gastric insufflation because of higher ventilatory pressures. However there are conflicting data with improvement of GERD symptoms in CPAP treated OSA patients. The investigators aim to compare the risk of gastric insufflation regarding mask ventilation technique, with or without positive end expiratory pressure. For measurements a High Resolution Impedance Manometry Catheter is used.


Description:

Anesthetic induction agents cause a number of physiological changes within the respiratory system. Almost every induction agent causes apnoea. There is a reduction of FRC and an increase in airway resistance. Combined with preoxygenation with a high fraction of oxygen there is a significant risk of pulmonary atelectasis. Adding a continuous positive pressure during ventilation of the apnoeic patient improves many of the respiratory effects caused by induction agents. However the added continuous pressure will increase the total inspiratory pressure and a high inspiratory pressure is associated with an increased risk of gastric insufflation during mask ventilation. On the other hand there are data suggesting that continuous positive pressure is beneficial in treatment of GERD-symptoms.

The investigators hypothesis is, if performed correctly, that the continuous positive pressure will not increase the risk of gastric insufflation. In order to investigate this matter 30 healthy human subjects will undergo anesthetic induction, 15 with no PEEP added and 15 with a PEEP of 10 cm H2O during mask ventilation.

Protocol:

1. Preoxygenation, 100 % oxygen via Face mask for 3 minutes with 0 PEEP or 10 cm H2O PEEP.

2. Start of Remifentanil Target Controlled Infusion, target concentration 6 ng/ml.

3. Propofol 2-2.5mg/kg to adequate depth of anesthesia.

4. 30 seconds after apnea mask ventilation with Dräger ZEUS IE starting with an inspiratory pressure of 3cm H2O that is gradually increased to a maximum of 30 cm H20 or to signs of air insufflation in the esophagus. Group 1 with 0 PEEP and group 2 with 10 cm H2O PEEP.

5. End of Remifentanil- and Propofol infusion.

Pressures and passage of air or liquid from pharynx to stomach will be continuously registered during the procedure. For measurements a High Resolution Impedance Manometry Catheter with the ability to measure pressures and impedance simultaneously will be used.

The esophagus and the stomach is divided into four functional units for analysis.

1. The upper esophageal sphincter

2. The esophageal body (3 cm below upper esophageal sphincter to 3 cm over the lower esophageal sphincter)

3. The lower esophageal sphincter

4. The stomach (3 cm below the lower esophageal sphincter)

The different units are detected in pressure plots where the levels of pressure reflects the anatomical units. Manometric values is specified in mmHg. For detection of passage of air and flow of liquid an impedance baseline is set before measurements start. Passage of air is defined as a sudden rise in impedance of 1 kΩ in anterograde direction. Detection of fluid is defined as a 50% decline in impedance. For analysis of data Mano View analysis software is used.

Pressures and impedance will be continuously recorded during the time frame from preoxygenation to maximum inspiratory pressures are reached. Data will be analysed at each level of pressure 3, 5, 10, 15, 20, 25 and 30 cm H2O. Contained data will be statistically compared between groups.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Male or female age 18-40 years

- Signed and informed consent

- Subject will and is assumed to be able to follow protocol

Exclusion Criteria:

- Known gastro intestinal/heart/lung/kidney or neurological disease

- Use of drugs that interfere with esophageal motility

- Diabetes

- Pregnancy or breastfeeding

- BMI >30

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Mask ventilation with PEEP via a face mask device
15 subjects will undergo anesthetic induction with an application of PEEP of 10 cm H2O during mask ventilation via a face mask. 15 subjects will undergo anesthetic induction without PEEP during mask ventilation via a face mask.

Locations

Country Name City State
Sweden Örebro University Hospital Örebro

Sponsors (1)

Lead Sponsor Collaborator
Örebro University, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Pressure changes in the stomach after gastric insufflation One hour Yes
Primary Level of inspiratory pressure for gastric insufflation One hour Yes
Secondary Pressure changes in the esophagus related to ventilation technique. One hour Yes
See also
  Status Clinical Trial Phase
Completed NCT01005251 - Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI Phase 2
Recruiting NCT05976165 - A Study of Breath Testing for Small Intestinal Bacterial Overgrowth N/A
Completed NCT00703534 - Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms Phase 2
Terminated NCT01199679 - Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD) N/A
Completed NCT00842387 - Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) N/A
Recruiting NCT01858584 - Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate N/A